Source:http://linkedlifedata.com/resource/pubmed/id/20479634
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
2010-6-11
|
| pubmed:abstractText |
In the ARTEMIS and TITAN trials of protease inhibitor-based HAART, patients with earlier HIV RNA suppression (HIV RNA <50 copies/ml less than 12 weeks after starting antiretrovirals) had similar rates of long-term HIV RNA undetectability to patients with later HIV RNA suppression (HIV RNA <50 copies/ml after 12-24 weeks). Analyses of seven other large clinical trials also show no consistent correlations between the early dynamics of HIV RNA decline and long-term virological suppression.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1473-5571
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
19
|
| pubmed:volume |
24
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1591-3
|
| pubmed:meshHeading |
pubmed-meshheading:20479634-Anti-HIV Agents,
pubmed-meshheading:20479634-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:20479634-CD4 Lymphocyte Count,
pubmed-meshheading:20479634-Clinical Trials, Phase III as Topic,
pubmed-meshheading:20479634-HIV Infections,
pubmed-meshheading:20479634-HIV-1,
pubmed-meshheading:20479634-Humans,
pubmed-meshheading:20479634-RNA, Viral,
pubmed-meshheading:20479634-Randomized Controlled Trials as Topic
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Does earlier HIV RNA suppression provide long-term benefits?
|
| pubmed:affiliation |
Chelsea and Westminster Hospital, London UK.
|
| pubmed:publicationType |
Journal Article
|